Vinod Khosla (Khosla Ventures Founder) – Health 2.0 Silicon Valley Meet-up (Jul 2014)


Chapters

00:00:17 Digital Health: Radical Opportunity for New Science, Medicine, and Startups
00:05:16 Future of Healthcare: Innovation Powered by Mobile and Data
00:09:07 Mobile Healthcare Innovations: Empowering Personalized and Continuous Health Monitoring
00:12:03 Innovation in Healthcare Beyond Digital Health
00:16:58 Advice from a Successful Entrepreneur: Embracing Innovation, Breaking Rules, and Maintaining a
00:20:50 Entrepreneurial Tactics and Vision in Healthcare Technology
00:33:04 Investment Innovation for the Average Person
00:35:05 The Future of Behavior Modification Through Software
00:38:43 Technology-Enabled Behavior Modification: Possibilities and Challenges
00:49:37 Key Factors in Startup Investment Decisions

Abstract



“Revolutionizing Healthcare: How Digital Innovation and Entrepreneurial Vision are Shaping the Future”

In a groundbreaking analysis, Vinod Khosla’s insights into digital health reveal a transformative era in healthcare, poised to redefine patient care and medical practice. Central to this transformation is the convergence of computing power, mobile technology, and machine learning, catalyzing advancements from continuous heart monitoring (AliveCore) to mental health interventions (Ginger.io). Khosla’s vision extends to a future where healthcare is universally accessible, and patients become the CEOs of their own health, empowered by predictive care and advanced technology. This shift not only promises radical changes in medical roles, emphasizing ethical decision-making over routine tasks, but also necessitates a reevaluation of medical education, prioritizing emotional intelligence. Amidst these seismic shifts, challenges in the bureaucratic nature of hospitals and health plans emerge, alongside the potential for disruptive innovation in every medical specialty.

Main Ideas and Expansion:

Digital Health’s Transformative Opportunities:

Digital health is at the forefront of revolutionizing healthcare, offering significant administrative improvements and advancements in medical science. Healthcare costs will likely decrease substantially, approaching a near-free state, with access becoming more equitable worldwide. The consumer’s role is expected to evolve dramatically, becoming the central figure in managing their health, backed by enhanced information and predictive care. This paradigm shift predicts a fundamental change in the doctor’s role, focusing more on ethical decision-making and mentorship.

Moreover, innovations across sectors, including healthcare, biology, and chemistry, hold immense promise. New developments in physics and chemistry, such as reimagined food products like eggs, beef, and salt, driven by fundamental science, exemplify this potential. A shift from enterprise software to physics and chemistry-driven innovation reflects the evolving landscape of innovation.

Khosla’s Vision for Healthcare Innovation:

Khosla identifies a unique opportunity in healthcare, likening it to a stable three-legged stool supported by advancements in computing, affordable sensors, and machine learning. He highlights the alarming rate of medical errors and the transformative potential of these technologies to improve patient outcomes. His vision is characterized by a commitment to innovation, especially in the context of healthcare software in developing countries. Khosla emphasizes the current time as an ideal period for investing in healthcare, particularly for those interested in innovation, driving change, and contributing to medical advancements.

When investing, Khosla emphasizes the significance of improving outcomes over reducing costs. Positive outcomes lead to greater impact and, eventually, financial success. Mission-driven entrepreneurs tend to outperform mercenary-driven ones in the long run.

Case Studies in Innovation: AliveCore, Ginger.io, Cellscope:

Innovations like AliveCore’s ECG machine, Ginger.io’s mental health app, and Cellscope’s smartphone-based otoscope exemplify the breadth of digital health’s impact. These technologies democratize access to specialized care, offering continuous monitoring, personalized interventions, and remote examinations. Khosla shares his personal experience using a prototype device that generated 10 million data points per day, far exceeding the limited data typically collected during doctor visits.

Broader Innovation Beyond Digital Health:

Innovation in healthcare extends to fields like physics, chemistry, and biology. Khosla points out the reinvention of basic food items using scientific principles and the increasing demand for expertise in these areas. He argues that prioritizing patient outcomes over costs leads to greater long-term impact and financial success.

Challenges for Traditional Healthcare Institutions:

Hospitals and health plans face significant hurdles in adapting to digital health due to their size and bureaucratic nature. However, partnerships with innovative institutions can facilitate this transition. Khosla draws parallels with Square’s success in the payments industry, attributed to its disregard for legacy knowledge and norms.

Square’s founder, Jack Dorsey, attributed their success to hiring individuals with fresh perspectives, not burdened by existing industry knowledge. This approach allowed them to challenge conventional practices and disrupt the market.

Entrepreneurship and Innovation Perspectives:

Khosla emphasizes the value of breaking rules and maintaining a balance of optimism, self-confidence, and paranoia in entrepreneurship. His personal journey, inspired by Andy Grove, reflects the essence of innovative thinking, uninhibited by past experiences.

Khosla highlights the importance of innovations across sectors, the potential for value creation in adjacent markets, and the need for disruptive innovation in healthcare fields like dentistry. He emphasizes the role of entrepreneurs in pursuing their vision persistently while adapting their approach and securing resources. Khosla also stresses the importance of embracing failure as a learning opportunity and the need for independent thinking in venture capital.

Key Insights from Khosla’s Presentation:

Khosla discusses various aspects of healthcare technology startups, including the importance of systems that bring new solutions, the role of administrative systems in improving efficiency, and the need to address the needs of the uninsured. He also stresses the significance of embracing failure and avoiding herd mentality in entrepreneurship.

The Future of Investment and Healthcare Software:

Khosla’s insights extend to investment strategies, highlighting the value of technical innovations irrespective of immediate business models. He underscores the role of a strong team in realizing innovative ideas and acknowledges the FDA’s cautious yet progressive approach. While predictions may be inaccurate, the current healthcare system will not persist indefinitely.

Opportunities for the Average Investor:

Traditionally, reliable investment advice was inaccessible to the average person, often leading them to seek guidance from unqualified sources. Good systems can address this issue by providing reliable advice to a broader audience. Quantopian, a Boston-based company, showcases robust algorithms created by top machine learning professionals, allowing investors to make informed decisions based on performance history. By eliminating intermediaries, Quantopian democratizes investment advice, enabling any investor to subscribe to its services.

Software’s Role in Behavior Modification and Healthcare:

Vinod Khosla emphasizes the importance of behavioral medicine, urging entrepreneurs to focus on behavior modification rather than just selling devices. He highlights the success of WellDoc, a software app approved by the FDA as a pharmaceutical drug, which achieved higher blood sugar reduction than traditional drugs. Challenges faced by WellDoc, such as refill requirements and formulary price, underscore the need for practical solutions. Khosla outlines two approaches to behavior modification in healthcare: bucking the system and focusing solely on behavior modification or following the full FDA process. He predicts the prevalence of software drugs in mental health, effectively addressing various mental health issues.

VCs, Entrepreneurs, and Behavior Modification:

Khosla advises entrepreneurs to consider all factors affecting their business and recommends the book “Lean Startup” for guidance on practical iterations and learning. He emphasizes the effectiveness of different apps and approaches to behavior modification for different individuals. Citing examples like Think, which allows users to experience the effects of coffee or meditation, Khosla highlights the ethical implications of brain hacking for behavior modification. Entrepreneurs should learn from rejection and solicit feedback, regardless of their funding status. Data aggregation will likely become a valuable function, with consumers ultimately deciding the preferred form of data aggregation.

Supplemental Updates:

Investment Approach:

– Khosla Ventures invests in a wide range of businesses, from those with clear business models to those focused solely on significant technical innovation.

– Investments range from $100,000 to $50 million.

– Key criteria include the quality of the team, their innovative thinking, and their vision for the future.

Team and Idea Quality:

– Khosla emphasizes the importance of exceptional teams and their ability to think deeply and present problems effectively.

– The firm actively seeks out talented individuals and welcomes resumes, business plans, and feedback.

Focus on Successful Companies:

– Khosla criticizes VCs who prioritize management fees over building successful companies.

– He believes that many VCs are focused on the right approach, which is fostering the growth of strong, thriving businesses.

Understanding the FDA’s Perspective:

– Khosla acknowledges the frustrations entrepreneurs may face when dealing with the FDA.

– He emphasizes the FDA’s cautious approach, driven by the need to avoid mistakes that could lead to media scrutiny and firings.

– He highlights examples of FDA approvals, such as LDOC and over-the-counter ECG machines, demonstrating their willingness to embrace innovation.

FDA’s Constraints and Innovative Thinking:

– Khosla explains that the FDA’s constraints differ from those in Silicon Valley, impacting their decision-making process.

– He commends the FDA for their innovative thinking, particularly in cases where the potential harm is minimal.

Contact Information:

– Khosla encourages attendees to email him directly at vk@coastaladventures.com for any inquiries or feedback.

– He emphasizes his commitment to responding to every email he receives.



In conclusion, Khosla’s vision for healthcare represents a seismic shift towards a more accessible, efficient, and patient-centered system. His insights encourage a reimagining of healthcare roles, education, and the entrepreneurial mindset, underscoring the critical intersection of technology and healthcare. As the landscape of healthcare continues to evolve, these insights offer a roadmap for future innovations and a glimpse into a more equitable and effective healthcare system.


Notes by: QuantumQuest